A retrospective study of CHEMOSAT in patients with Metastatic Uveal Melanoma

Trial Profile

A retrospective study of CHEMOSAT in patients with Metastatic Uveal Melanoma

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jul 2016

At a glance

  • Drugs Melphalan (Primary)
  • Indications Uveal melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2016 Results published in a Delcath Systems media release.
    • 06 Jul 2016 According to a Delcath Systems media release, data from this study were presented in an oral presentation at the 6th European Post-Chicago Melanoma/Skin Cancer Meeting.
    • 04 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top